CTI BioPharma Corp. Company Profile (NASDAQ:CTIC)

About CTI BioPharma Corp.

CTI BioPharma Corp. logoCTI BioPharma Corp. (CTI) is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers to patients and healthcare providers. The Company is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). It is also engaged in evaluating pacritinib for the treatment of adult patients with myelofibrosis. Its earlier stage product candidate, tosedostat, is an oral, once-daily aminopeptidase inhibitor that has demonstrated responses in patients with acute myeloid leukemia (AML). It also evaluates its pipeline candidate paclitaxel poliglumex (Opaxio), which targets solid tumors. It is evaluating Opaxio through cooperative group sponsored trials and investigator-sponsored trials (ISTs), such as the ongoing maintenance therapy trial in patients with ovarian cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CTIC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.39
  • 50 Day Moving Average: $0.369
  • 200 Day Moving Average: $0.428
  • 52-Week Range: $279,604,000.00 - $0.25
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.67
  • P/E Growth: 0.000
  • Market Cap: $107.65M
  • Outstanding Shares: 279,604,000
  • Beta: 1.13
  • Net Margins: -133.07%
  • Return on Equity: -268.19%
  • Return on Assets: -69.71%
  • Debt-to-Equity Ratio: 0.42%
  • Current Ratio: 2.18%
  • Quick Ratio: 2.12%
Additional Links:
Companies Related to CTI BioPharma Corp.:

Analyst Ratings

Consensus Ratings for CTI BioPharma Corp. (NASDAQ:CTIC) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: $0.91 (137.23% upside)

Analysts' Ratings History for CTI BioPharma Corp. (NASDAQ:CTIC)
DateFirmActionRatingPrice TargetDetails
8/29/2016Piper Jaffray Cos.Reiterated RatingNeutral$0.75View Rating Details
2/10/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details
2/10/2016WallachBeth CapitalDowngradeHold -> SellView Rating Details
2/8/2016S&P Equity ResearchLower Price Target$0.48 -> $0.39View Rating Details
8/14/2015Roth CapitalReiterated RatingBuy$4.50View Rating Details
6/1/2015Janney Montgomery ScottReiterated RatingBuy -> Fair Value$3.50 -> $1.94View Rating Details
5/10/2015HC WainwrightReiterated RatingBuy$6.00 -> $4.00View Rating Details
(Data available from 9/26/2014 forward)


Earnings History for CTI BioPharma Corp. (NASDAQ:CTIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q2($0.10)($0.07)ViewN/AView Earnings Details
5/10/2016Q1($0.04)$0.01ViewN/AView Earnings Details
2/16/2016Q4($0.18)($0.13)ViewN/AView Earnings Details
11/5/2015Q315($0.12)($0.19)$18.89 million$1.00 millionViewListenView Earnings Details
8/6/2015Q215($0.10)($0.19)$12.77 million$1.10 millionViewListenView Earnings Details
5/6/2015Q115($0.14)($0.16)$9.84 million$2.73 millionViewListenView Earnings Details
3/12/2015Q414($0.18)($0.27)$2.48 million$17.80 millionViewListenView Earnings Details
10/29/2014Q3$0.03$0.03ViewListenView Earnings Details
8/4/2014Q2($0.12)($0.19)ViewListenView Earnings Details
4/29/2014Q114($0.17)($0.20)$1.10 million$1.40 millionViewN/AView Earnings Details
3/4/2014Q4($0.16)$0.08$1.26 million$32.90 millionViewListenView Earnings Details
2/28/2013Q4 2012($0.20)($0.20)$1.00 millionViewListenView Earnings Details
11/1/2012Q312($0.38)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CTI BioPharma Corp. (NASDAQ:CTIC)
Current Year EPS Consensus Estimate: $-0.190 EPS
Next Year EPS Consensus Estimate: $-0.230 EPS


Dividend History for CTI BioPharma Corp. (NASDAQ:CTIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CTI BioPharma Corp. (NASDAQ:CTIC)
Insider Ownership Percentage: 3.01%
Institutional Ownership Percentage: 28.96%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/24/2016James A BiancoCEOSell10,000$0.37$3,700.00View SEC Filing  
5/27/2016James A BiancoCEOSell10,000$0.45$4,500.00View SEC Filing  
4/29/2016James A BiancoCEOSell10,000$0.52$5,200.00View SEC Filing  
3/28/2016James A BiancoCEOSell10,000$0.49$4,900.00View SEC Filing  
3/21/2016James A BiancoCEOSell318,169$0.55$174,992.95View SEC Filing  
3/4/2016Matthew PlunkettEVPSell10,000$0.59$5,900.00View SEC Filing  
2/26/2016Jack W SingerEVPSell15,000$0.63$9,450.00View SEC Filing  
2/26/2016James A BiancoCEOSell10,000$0.63$6,300.00View SEC Filing  
2/16/2016James A BiancoCEOSell100,000$0.42$42,000.00View SEC Filing  
2/4/2016Matthew PlunkettEVPSell10,000$1.15$11,500.00View SEC Filing  
1/29/2016Jack W. SingerEVPSell15,000$1.18$17,700.00View SEC Filing  
1/29/2016James A BiancoCEOSell10,000$1.20$12,000.00View SEC Filing  
1/8/2016Value Fund L P BiotechnologyInsiderBuy1,001,327$1.22$1,221,618.94View SEC Filing  
1/4/2016Matthew PlunkettEVPSell10,000$1.21$12,100.00View SEC Filing  
12/30/2015James A. BiancoCEOSell110,000$1.26$138,600.00View SEC Filing  
12/28/2015James A. BiancoCEOSell10,000$1.29$12,900.00View SEC Filing  
12/18/2015Jack W. SingerEVPSell15,000$1.18$17,700.00View SEC Filing  
12/4/2015Matthew PlunkettEVPSell10,000$1.00$10,000.00View SEC Filing  
11/27/2015Jack W. SingerEVPSell15,000$1.21$18,150.00View SEC Filing  
11/27/2015James A BiancoCEOSell10,000$1.23$12,300.00View SEC Filing  
11/19/2015Louis A. BiancoEVPSell15,000$1.13$16,950.00View SEC Filing  
10/30/2015James A BiancoCEOSell260,000$1.35$351,000.00View SEC Filing  
10/29/2015Louis A. BiancoEVPSell10,000$1.41$14,100.00View SEC Filing  
10/23/2015Jack W. SingerEVPSell15,000$1.62$24,300.00View SEC Filing  
10/22/2015Louis A BiancoEVPSell10,000$1.58$15,800.00View SEC Filing  
10/5/2015Matthew PlunkettEVPSell10,000$1.52$15,200.00View SEC Filing  
9/30/2015Jack W. SingerEVPSell100,000$1.42$142,000.00View SEC Filing  
9/30/2015James A. BiancoCEOSell600,000$1.43$858,000.00View SEC Filing  
9/30/2015Richard L. LoveDirectorSell13,660$1.45$19,807.00View SEC Filing  
9/29/2015Louis A. BiancoEVPSell170,000$1.41$239,700.00View SEC Filing  
9/25/2015Jack W. SingerEVPSell15,000$1.64$24,600.00View SEC Filing  
9/24/2015Matthew PlunkettEVPSell75,869$1.57$119,114.33View SEC Filing  
9/4/2015Matthew PlunkettEVPSell10,000$1.54$15,400.00View SEC Filing  
8/28/2015Jack W. SingerEVPSell15,000$1.58$23,700.00View SEC Filing  
7/24/2015Jack W SingerEVPSell15,000$1.91$28,650.00View SEC Filing  
7/23/2015Louis A BiancoEVPSell10,000$1.91$19,100.00View SEC Filing  
7/6/2015Matthew PlunkettEVPSell10,000$1.95$19,500.00View SEC Filing  
6/26/2015Jack W SingerEVPSell15,000$2.07$31,050.00View SEC Filing  
6/25/2015Louis A BiancoEVPSell10,000$2.18$21,800.00View SEC Filing  
6/4/2015Matthew PlunkettEVPSell10,000$2.06$20,600.00View SEC Filing  
5/22/2015Jack W SingerEVPSell15,000$1.74$26,100.00View SEC Filing  
5/21/2015Louis A BiancoEVPSell10,000$1.80$18,000.00View SEC Filing  
5/4/2015Matthew PlunkettEVPSell10,000$1.86$18,600.00View SEC Filing  
4/24/2015Jack W SingerEVPSell15,000$1.96$29,400.00View SEC Filing  
4/23/2015Louis A BiancoEVPSell10,000$1.93$19,300.00View SEC Filing  
4/6/2015Matthew PlunkettEVPSell16,569$1.88$31,149.72View SEC Filing  
3/23/2015James A BiancoCEOSell175,199$1.95$341,638.05View SEC Filing  
3/23/2015Matthew PlunkettEVPSell59,130$1.96$115,894.80View SEC Filing  
3/20/2015Louis A BiancoEVPSell63,000$1.94$122,220.00View SEC Filing  
2/27/2015Jack W SingerEVPSell15,000$2.35$35,250.00View SEC Filing  
2/5/2015Louis A BiancoEVPSell10,000$2.22$22,200.00View SEC Filing  
2/4/2015Matthew PlunkettEVPSell12,000$2.22$26,640.00View SEC Filing  
1/8/2015Louis A BiancoEVPSell10,000$2.32$23,200.00View SEC Filing  
1/5/2015Matthew PlunkettEVPSell12,000$2.36$28,320.00View SEC Filing  
12/19/2014James A BiancoCEOSell40,000$2.44$97,600.00View SEC Filing  
12/4/2014Louis A BiancoEVPSell10,000$2.25$22,500.00View SEC Filing  
11/6/2014Louis A BiancoEVPSell10,000$2.37$23,700.00View SEC Filing  
10/6/2014Matthew PlunkettEVPSell12,000$2.39$28,680.00View SEC Filing  
9/23/2014Matthew PlunkettEVPSell103,635$2.56$265,305.60View SEC Filing  
9/22/2014James A BiancoCEOSell307,068$2.53$776,882.04View SEC Filing  
9/22/2014Matthew PlunkettEVPSell51,817$2.58$133,687.86View SEC Filing  
9/19/2014Louis A BiancoEVPSell145,000$2.59$375,550.00View SEC Filing  
9/4/2014Matthew PlunkettEVPSell27,301$2.48$67,706.48View SEC Filing  
8/15/2014James A BiancoCEOSell40,000$2.54$101,600.00View SEC Filing  
8/4/2014Matthew PlunkettEVPSell12,000$2.48$29,760.00View SEC Filing  
7/10/2014Louis A BiancoEVPSell10,000$2.73$27,300.00View SEC Filing  
7/7/2014Matthew PlunkettEVPSell12,000$2.89$34,680.00View SEC Filing  
6/27/2014James A BiancoCEOSell50,000$2.84$142,000.00View SEC Filing  
6/5/2014Louis A BiancoEVPSell10,000$2.97$29,700.00View SEC Filing  
5/1/2014Louis BiancoEVPSell10,000$2.91$29,100.00View SEC Filing  
3/28/2014Vartan GregorianDirectorSell82,000$3.41$279,620.00View SEC Filing  
3/25/2014Phillip Phd NudelmanDirectorSell100,000$3.56$356,000.00View SEC Filing  
3/24/2014Jack SingerEVPSell60,000$3.47$208,200.00View SEC Filing  
3/21/2014James BiancoCEOSell395,000$3.83$1,512,850.00View SEC Filing  
3/21/2014Matthew PlunkettEVPSell170,000$3.73$634,100.00View SEC Filing  
3/7/2014Fred TellingDirectorSell72,095$3.75$270,356.25View SEC Filing  
9/23/2013James A BiancoCEOSell130,551$1.50$195,826.50View SEC Filing  
8/30/2013James A BiancoCEOSell25,925$1.08$27,999.00View SEC Filing  
8/9/2013James A BiancoCEOSell40,000$1.07$42,800.00View SEC Filing  
8/7/2013Mary Oneil MundingerDirectorSell125,000$1.06$132,500.00View SEC Filing  
8/6/2013Phillip M Phd NudelmanDirectorSell50,000$1.09$54,500.00View SEC Filing  
7/26/2013James A BiancoCEOSell25,688$1.09$27,999.92View SEC Filing  
6/28/2013James A BiancoCEOSell26,053$1.08$28,137.24View SEC Filing  
6/5/2013Jack W SingerEVPSell10,000$1.26$12,600.00View SEC Filing  
5/31/2013James A BiancoCEOSell28,000$1.22$34,160.00View SEC Filing  
5/31/2013Louis A BiancoEVPSell33,712$1.24$41,802.88View SEC Filing  
5/30/2013Fred TellingDirectorSell64,798$1.24$80,349.52View SEC Filing  
5/24/2013Richard L LoveDirectorSell23,000$1.21$27,830.00View SEC Filing  
5/10/2013James A BiancoCEOSell25,000$1.16$29,000.00View SEC Filing  
5/9/2013Louis A BiancoEVPSell50,000$1.15$57,500.00View SEC Filing  
3/11/2013Jack W SingerEVPSell13,000$1.28$16,640.00View SEC Filing  
8/10/2012James A BiancoCEOSell10,000$0.42$4,200.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CTI BioPharma Corp. (NASDAQ:CTIC)
News IconKeen Investors Find News on CTI BioPharma Corp. (NASDAQ:CTIC) - Duncan Research (NASDAQ:CTIC)
www.duncanindependent.com - September 24 at 4:15 PM
News IconUnder the Microscope, Zeroing in at CTI BioPharma Corp. (NASDAQ:CTIC) - Duncan Research (NASDAQ:CTIC)
www.duncanindependent.com - September 23 at 9:33 AM
prnewswire.com logoCTI BioPharma Granted 180 Day Extension By NASDAQ To Regain ... - PR Newswire (press release) (NASDAQ:CTIC)
www.prnewswire.com - September 23 at 9:33 AM
News IconNews review of 2 biotech stocks: CTI BioPharma Corp. (NASDAQ:CTIC), PTC Therapeutics, Inc. (NASDAQ:PTCT) - The Voice Registrar (NASDAQ:CTIC)
voiceregistrar.com - September 23 at 9:33 AM
finance.yahoo.com logoCTI BioPharma Granted 180 Day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule (NASDAQ:CTIC)
finance.yahoo.com - September 22 at 10:03 AM
News IconPenny Stock Investors Keen on Shares of CTI BioPharma Corp. (NASDAQ:CTIC) - Duncan Research (NASDAQ:CTIC)
www.duncanindependent.com - September 21 at 5:01 PM
News IconCTI BioPharma Corp. (NASDAQ:CTIC) Near Term Price Target Update on The Stock - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 21 at 8:42 AM
biz.yahoo.com logoCTI BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:CTIC)
biz.yahoo.com - September 20 at 8:06 AM
News IconMean Consensus Price Target for CTI BioPharma Corp. (NASDAQ:CTIC) is Set at 0.75 - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 18 at 4:21 PM
News IconCTI BioPharma Corp. (NASDAQ:CTIC): A look at the Stock Performance Today and Where it Could be Headed - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 18 at 4:21 PM
News IconCTI BioPharma Corp. (NASDAQ:CTIC): Stock Update & Outlook on Consensus Direction - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 17 at 4:22 PM
News IconKeen Investors Seek Information on CTI BioPharma Corp. (NASDAQ:CTIC) - Duncan Research (NASDAQ:CTIC)
www.duncanindependent.com - September 16 at 4:21 PM
News IconStock Update, a Closer Look at CTI BioPharma Corp. (NASDAQ:CTIC) - Duncan Research (NASDAQ:CTIC)
www.duncanindependent.com - September 16 at 8:05 AM
News IconKeen Investors Narrowing Their Focus on CTI BioPharma Corp. (NASDAQ:CTIC) - Duncan Research (NASDAQ:CTIC)
www.duncanindependent.com - September 15 at 9:25 AM
News IconInvestor Scope: Checking in on Shares of CTI BioPharma Corp. (NASDAQ:CTIC) - Post News (NASDAQ:CTIC)
www.kentuckypostnews.com - September 14 at 8:05 AM
News IconHoning in on CTI BioPharma Corp. (NASDAQ:CTIC) Shares, Analysts Take Stock - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 13 at 9:20 AM
News IconCTI BioPharma Corp. (NASDAQ:CTIC) are Projected to Reach 0.75, According to Analysts - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 11 at 8:59 AM
News IconCTI BioPharma Corp. (NASDAQ:CTIC) Shares Handed One Year Price Objective - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 11 at 8:59 AM
News IconMarket Review: Watching Session Activity of CTI BioPharma Corp. (NASDAQ:CTIC) Shares - Post News (NASDAQ:CTIC)
www.kentuckypostnews.com - September 9 at 4:20 PM
News IconCTI BioPharma Corp. (NASDAQ:CTIC) Shares Are Moving, But Where to go From Here? - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 9 at 9:18 AM
News IconTrading Update: Following Activity of CTI BioPharma Corp. (NASDAQ:CTIC) Shares During the Current Session - Post News (NASDAQ:CTIC)
www.kentuckypostnews.com - September 8 at 8:13 AM
News IconCTI BioPharma Corp. (NASDAQ:CTIC): Can It Hit The Consensus of $0.75? - Frisco Fastball (NASDAQ:CTIC)
friscofastball.com - September 8 at 8:13 AM
News IconShares Gapping Higher Pre-Bell: CTI BioPharma Corp. (NASDAQ:CTIC) - Post News (NASDAQ:CTIC)
www.kentuckypostnews.com - September 1 at 10:19 AM
News IconIntraday Active Biotech Stocks News: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), CTI BioPharma Corp. (NASDAQ ... - The Voice Registrar (NASDAQ:CTIC)
voiceregistrar.com - September 1 at 10:19 AM
streetinsider.com logoPiper Remains Neutral on CTI BioPharma (CTIC) Update Top-Line PERSIST-2 Data (NASDAQ:CTIC)
www.streetinsider.com - August 31 at 4:25 PM
News IconCTI BioPharma Corp.'s (CTIC): Stock in the Traders Limelight - Hot Stocks Point (NASDAQ:CTIC)
www.hotstockspoint.com - August 31 at 9:15 AM
News IconShares Gapping Higher Pre-Market: CTI BioPharma Corp. (NASDAQ:CTIC) - Post News (NASDAQ:CTIC)
www.kentuckypostnews.com - August 30 at 6:40 AM
streetinsider.com logoCTI BioPharma (CTIC) Announces Pacritinib Phase 3 Met One co-Primary Endpoint; TSS Reduction Endpoint Missed (NASDAQ:CTIC)
www.streetinsider.com - August 29 at 4:39 PM
feeds.benzinga.com logoCTI BioPharma Meets One Of Two Endpoints In Phase 3 Trial (NASDAQ:CTIC)
feeds.benzinga.com - August 29 at 2:01 PM
rttnews.com logoCTI: Pacritinib End Trial For Advanced Myelofibrosis Met One Of Co-primary Goals (NASDAQ:CTIC)
www.rttnews.com - August 29 at 9:10 AM
finance.yahoo.com logoCTI BioPharma Announces Top-Line Results From PERSIST-2 Phase 3 Trial Of Pacritinib For High-Risk Patients With Advanced Myelofibrosis (NASDAQ:CTIC)
finance.yahoo.com - August 29 at 9:10 AM
News IconCTI BioPharma Corp (NASDAQ:CTIC) Analyst Opinion - The Independent Republic (NASDAQ:CTIC)
theindependentrepublic.com - August 24 at 4:26 PM
News IconTime To Put On The Watch List? - CTI BioPharma Corp. (NASDAQ:CTIC), Spark Therapeutics, Inc. (NASDAQ:ONCE) - The Voice Registrar (NASDAQ:CTIC)
voiceregistrar.com - August 18 at 9:41 PM
finance.yahoo.com logoCTI BIOPHARMA CORP Financials (NASDAQ:CTIC)
finance.yahoo.com - August 13 at 4:27 PM
publicnow.com logoBrainStorm Cell Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:CTIC)
www.publicnow.com - August 11 at 9:41 AM
equities.com logoCTI BioPharma Corp. (CTIC) Jumps 7.24% on August 03 | Equities ... - Equities.com (NASDAQ:CTIC)
www.equities.com - August 5 at 10:40 AM
rttnews.com logoEARNINGS SUMMARY: Details of CTI BioPharma Corp. Q2 Earnings Report (NASDAQ:CTIC)
www.rttnews.com - August 4 at 10:10 PM
sg.finance.yahoo.com logoCTI BioPharma reports 2Q loss (NASDAQ:CTIC)
sg.finance.yahoo.com - August 4 at 10:09 PM
finance.yahoo.com logoCTI BioPharma Reports Second Quarter 2016 Financial Results (NASDAQ:CTIC)
finance.yahoo.com - August 4 at 4:41 PM
fortune.com logoThe Insider Activity Don't Lie: CTI BioPharma Corp. (NASDAQ:CTIC ... - Review Fortune (NASDAQ:CTIC)
reviewfortune.com - August 2 at 4:35 PM
streetupdates.com logoAnalysts Ranking Activities: Sophiris Bio, Inc. (NASDAQ:SPHS) , CTI BioPharma Corp. (NASDAQ:CTIC) - Street Updates (NASDAQ:CTIC)
www.streetupdates.com - August 2 at 9:16 AM
streetupdates.com logoKeep an eye on Analyst Actions: CTI BioPharma Corp. (NASDAQ:CTIC) , Novo Nordisk A/S (NYSE:NVO) - Street Updates (NASDAQ:CTIC)
www.streetupdates.com - July 27 at 10:10 PM
equities.com logoCTI BioPharma Corp. (CTIC) Drops 9.12% on July 26 | Equities.com - Equities.com (NASDAQ:CTIC)
www.equities.com - July 27 at 10:10 PM
News IconShares Stumbling of Late: CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 23 at 8:08 AM
News IconStreet Analyst EPS Growth Watch in Review CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 22 at 3:52 PM
News IconConcentrating on Shares of CTI BioPharma Corp. (NASDAQ:CTIC) - Press Telegraph (NASDAQ:CTIC)
presstelegraph.com - July 21 at 4:36 PM
News IconMarket Minute - Focus on CTI BioPharma Corp. (NASDAQ:CTIC) Stock - TGP (NASDAQ:CTIC)
telanaganapress.com - July 21 at 4:36 PM
capitalcube.com logoETF’s with exposure to CTI BioPharma Corp. : July 20, 2016 (NASDAQ:CTIC)
www.capitalcube.com - July 20 at 12:18 PM
News IconSession Focus - Highlighting Shares of: CTI BioPharma Corp. (NASDAQ:CTIC) - TGP (NASDAQ:CTIC)
telanaganapress.com - July 19 at 4:32 PM
feeds.reuters.com logoUPDATE 1-Brainstorm's cell therapy succeeds in ALS mid-stage study (NASDAQ:CTIC)
feeds.reuters.com - July 18 at 9:49 AM


CTI BioPharma Corp. (NASDAQ:CTIC) Chart for Monday, September, 26, 2016

Last Updated on 9/26/2016 by MarketBeat.com Staff